Manufacturing of Pharmaceutical Drugs · New York

Perrigo : New York (PNY)

Bronx, NY · ~448 workers · 8 years of OSHA Injury Tracking Application data.

B
Good Safety Record
1.9
Avg TCR
3.3
Industry avg
0
Fatalities
Subscribe to safety-record updates (RSS)

The verdict

Perrigo : New York (PNY) runs at 58% of its industry's injury rate - safer than the typical Manufacturing of Pharmaceutical Drugs workplace, earning a grade B.

Perrigo : New York (PNY): 1.9 TCR = 58% of Manufacturing of Pharmaceutical Drugs BLS 3.3 · 8y Form 300A (see methodology below)

Perrigo : New York (PNY) safety composite

Perrigo : New York (PNY) scores strongest on fatalities (safer than 50% of same-industry peers) and weakest on total case rate (tcr) (safer than 43%), blended into one 0-100 breakdown against same-industry peers. A missing measure drops out and redistributes its weight rather than deflating the score. This is a per-dimension breakdown, distinct from the single letter grade above it (which weights TCR alone against the BLS industry benchmark).

D

45/100

Percentile-weighted across 3 of 3 measures

Total Case Rate (TCR)
D 1.9 per 100 workers

Safer than 43% of industry peers

DART rate
D 0.9 per 100 workers

Safer than 45% of industry peers

Fatalities
D 0

Safer than 50% of industry peers

Benchmarked live against every credibly-rated employer in the same NAICS industry code in the current OSHA extract (a segment must have at least 8 rated peers to benchmark). Not a legal or compliance determination; PlainSafetyScore's own weighting (TCR 40%, DART 35%, fatalities 25%).

TCR Δ

−2.2

2016→2023

Perrigo : New York (PNY) injury rate improved

Perrigo : New York (PNY)'s TCR fell 2.2 from 3.4 in 2016 to 1.2 in 2023. Peak filing year was 2016 at 3.4 TCR. In 2023, DART was 0.47× this establishment's average TCR (severity share of cases).

2016=3.4 · 2017=2.9 · 2018=1.7 · 2019=1.5 · 2020=1.3 · 2021=2.5 · 2022=0.8 · 2023=1.2

OSHA ITA Form 300A scorecard

Establishment book 325412 · Bronx, NY AT/BELOW-IND · MID

Grade B · TCR 1.9 · 58% of ind

  • DART 0.9 DART
  • RANK #25/64
  • PHOTO CENTRE
  • BOOK 8y book
  • INJ 57 inj
  • SIZE ~448 FTE

Nearest TCR peer: CENTRE (0.0 TCR gap)

Read with this employer → · Industry book → · New York employers → · Look up another →

Perrigo : New York (PNY) in the TCR neighbourhood

Average Total Case Rate among this establishment and nearest same-industry peers

TCR

What this shows Perrigo : New York (PNY) averages 1.9 TCR (58% of the Manufacturing of Pharmaceutical Drugs BLS benchmark).

Source U.S. Department of Labor, OSHA Injury Tracking Application (Form 300A) As of 2026-08-25

Perrigo : New York (PNY) TCR series: 2016=3.4 · 2017=2.9 · 2018=1.7 · 2019=1.5 · 2020=1.3 · 2021=2.5 · 2022=0.8 · 2023=1.2 · BLS 3.3

Where Perrigo : New York (PNY) falls in its industry

855 Manufacturing of Pharmaceutica establishments

Safer than 43% of graded establishments in this industry, whose median TCR is 1.6.

More dangerous than peersSafer than peers

Narrower to New York alone (the establishments it most directly competes with for workers and contracts): ranked #25 safest of 64 Manufacturing of Pharmaceutica employers in New York.

Perrigo : New York (PNY) (448 employees, TCR 1.9) among 29 same-industry peers, split at the industry median of 171 employees and a TCR of 1.6 2×2 strategic matrix plotting 30 entities by Average employees (X) and Total Case Rate (Y), with a crosshair dividing the plot into four quadrants. Larger & higher-riskSmaller & higher-riskLarger & saferSmaller & safer than peers 01,0002,0003,0004,000 051015 Average employees Total Case Rate Perrigo : New York (PNY)
Perrigo : New York (PNY) (448 employees, TCR 1.9) among 29 same-industry peers, split at the industry median of 171 employees and a TCR of 1.6

Perrigo : New York (PNY) has more employees than the Manufacturing of Pharmaceutical Drugs median and a higher injury rate than the industry's median TCR of 1.6. Workforce size and injury rate do not always move together within the same industry -- some of its smaller peers run higher rates than its larger ones, and vice versa.

Year-by-Year Safety Data

Year TCR DART Injuries Illnesses Fatalities
2023 1.2 0.9 4 0 0
2022 0.8 0.6 3 0 0
2021 2.5 0.8 7 2 0
2020 1.3 0.8 5 0 0
2019 1.5 1.2 6 0 0
2018 1.7 1.4 7 0 0
2017 2.9 2.9 10 2 0
2016 3.4 3.4 15 0 0

OSHA ITA peer cross-reference

Establishment peer ledger

325412 · NY · Bronx

855 Manufacturing of Pharmaceutical Drugs employers nationwide with a credible TCR · 21,008 rated employers in New York with headcount on file · 536 employers in Bronx, NY · 4 cross-state NAT-TCR peers · 4 cross-state NAT-SIZE peers. Closest matches by relationship code are listed below.

Rel Establishment Metric
NAICS-TCR CENTRE 1.9 TCR
NAICS-TCR BPI Labs, LLC 450 1.9 TCR
NAICS-TCR Corium Inc. 1.9 TCR
NAICS-TCR Ajinomoto Bio Pharma Services 1.9 TCR
STATE-SIZE MSD ORCHARD PARK 448 FTE
STATE-SIZE Sysco Syracuse 448 FTE
STATE-SIZE Bon Secours Medical Group PC 448 FTE
STATE-SIZE Williamson NY 449 FTE
CITY-NEAR BALDOR Bronx 1,450 FTE
CITY-NEAR Legends - New York Yankees 1,422 FTE
CITY-NEAR Bronx Zoo 1,356 FTE
CITY-NEAR WCS - Bronx Zoo of New York 1,265 FTE
NAT-TCR TUSTCA70 1.9 TCR
NAT-TCR Ferrara Candy Company 1.9 TCR
NAT-TCR CHICAGO, IL (Sheet) 1.9 TCR
NAT-TCR Renfro Corporation Clinton Distribution Center 1.9 TCR
NAT-SIZE Highland Il 448 FTE
NAT-SIZE North America : Mt. Vernon 448 FTE
NAT-SIZE The People Concern - 127th St. 448 FTE
NAT-SIZE The People Concern - Alexandria 448 FTE

Rel codes: NAICS-TCR · STATE-SIZE · CITY-NEAR · NAT-TCR/NAT-SIZE cross-state. Read with this employer →

Data Source: OSHA Injury Tracking Application (ITA), mandatory establishment-level injury/illness reports. Grades compare employer Total Case Rate (TCR) to BLS IIF industry benchmarks. Data covers years reported by this establishment: 2023, 2022, 2021, 2020, 2019, 2018, 2017, 2016. This is publicly available government data - not a legal determination of workplace conditions.

Read our methodology - how this data is sourced, computed, and verified.

Data sourced from official public datasets. See our methodology for details.